With the rampant COVID-19 epidemic situation still raging, Omicron subvariants BA.4 and BA.5 drive surge in cases and become the main COVID strain in HK. Through the Omicron Neutralizing Antibody Screening, you can better understand if there is an immune response after vaccination, whether you may have previously been infected by Omicron BA.1 BA.2 & BA.4/BA.5, and/or have adequate protection antibodies including neutralizing antibodies against future infection.
The Panbio™ COVID-19 Antigen Self-Test is a single-use, in vitro (i.e. outside the body) visually read rapid immunoassay that uses a nasal swab specimen for the qualitative detection of nucleocapsid protein SARS-CoV-2 antigen (Ag). The Panbio™ COVID-19 Antigen Self-Test is intended to be used manually by users for self-testing in a private setting, to aid in the diagnosis of an active SARS-CoV-2 infection. Children under 14 years should be supported by an adult.
The COVID-19 epidemic is still rampant across the globe, as of 13 June 2022, over 532 million cases have been reported worldwide, and 1.22 million confirmed cases in Hong Kong have been recorded since the first outbreak. The World Health Organization (WHO) stated that most people who have developed COVID-19 will be recovered, while some may experience a variety of post-COVID symptoms after their recovery, such as fatigue, breathlessness and chest-pain. Some experts also pointed out that some patients are experiencing palpitations and long-term effects of the lung, cardiovascular and neurological systems in their bodies. To alleviate the symptoms against recovered persons and hasten recovery from disease, Post COVID-19 Recovery Health Assessment (Advanced Plan) has been launched which included all health check-up items of “Essential Plan”, also covered COVID-19 antibody test, resting ECG, ultrasound screening and ferritin test, offering comprehensive and holistic care for the recovered persons.
The COVID-19 epidemic is still rampant across the globe, as of 13 June 2022, over 532 million cases have been reported worldwide, and 1.22 million confirmed cases in Hong Kong have been recorded since the first outbreak. The World Health Organization (WHO) stated that most people who have developed COVID-19 will be recovered, while some may experience a variety of post-COVID symptoms after their recovery, such as fatigue, breathlessness and chest-pain. Some experts also pointed out that some patients are experiencing palpitations and long-term effects of the lung, cardiovascular and neurological systems in their bodies. To alleviate the symptoms against recovered persons and hasten recovery from disease, Post COVID-19 Recovery Health Assessment (Essential Plan) has been launched which incorporates the examination of inflammation, chest X-Ray, liver and renal function for understanding the health status better.
The Panbio™ COVID-19 Antigen Self-Test is a single-use, in vitro (i.e. outside the body) visually read rapid immunoassay that uses a nasal swab specimen for the qualitative detection of nucleocapsid protein SARS-CoV-2 antigen (Ag). The Panbio™ COVID-19 Antigen Self-Test is intended to be used manually by users for self-testing in a private setting, to aid in the diagnosis of an active SARS-CoV-2 infection. Children under 14 years should be supported by an adult.
AESKU COVID-19 Rapid Antigen Test is an immunological method that is using nasal swab specimen for the qualitative detection of SARS-CoV-2 antigens. It is able to detect the presence of certain COVID-19 variants (Omicron and Delta)^. AESKU COVID-19 Rapid Antigen Test is developed and made in Germany, being externally evaluated by ESfEQA and CE-certified, and is being used by multiple private hospitals in Hong Kong for detecting the presence of COVID-19. The rapid antigen test is easy and convenient, allowing users to perform the tests on their own, and results to be illustrated in 15 minutes. There are 2 sets of test device inside 1 pack, which allows double confirmation upon suspected positive cases. The test is eligible for people of all ages, and any person under 12 years should be accompanied by adults.
Our first batch of “AESKU Covid-19 Rapid Antigen Test” sales received an overwhelming response and were sold out. To safeguard your health and thanks for your ongoing support, the second batch will be up for grabs again at below discount price: